98 related articles for article (PubMed ID: 30711948)
1. Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
Kusuhara Y; Daizumoto K; Kawai K; Hirayama K; Kowada M; Shintani T; Fukuhara Y; Dondoo TO; Ozaki K; Tsuda M; Fukawa T; Nakatsuji H; Bando Y; Uehara H; Fukumori T; Takahashi M; Kanayama HO
Anticancer Res; 2019 Feb; 39(2):703-711. PubMed ID: 30711948
[TBL] [Abstract][Full Text] [Related]
2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.
Ye J; Zhang Y; Cai Z; Jiang M; Li B; Chen G; Zeng Y; Liang Y; Wu S; Wang Z; He H; Zhong W; Wu CL
BMC Urol; 2018 Sep; 18(1):82. PubMed ID: 30249226
[TBL] [Abstract][Full Text] [Related]
4. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
[TBL] [Abstract][Full Text] [Related]
5. FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape.
Fu HY; Li C; Yang W; Gai XD; Jia T; Lei YM; Li Y
Acta Histochem; 2013 Mar; 115(2):151-7. PubMed ID: 22749378
[TBL] [Abstract][Full Text] [Related]
6. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
7. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
8. ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer.
Gao ZY; Yu F; Jia HX; Ye Z; Yao SJ
Kaohsiung J Med Sci; 2020 Dec; 36(12):1021-1029. PubMed ID: 32767492
[TBL] [Abstract][Full Text] [Related]
9. Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer.
Nguyen DP; O'Malley P; Al Hussein Al Awamlh B; Furrer MA; Mongan NP; Robinson BD; Wang GJ; Scherr DS
Clin Genitourin Cancer; 2017 Apr; 15(2):256-262.e1. PubMed ID: 27324053
[TBL] [Abstract][Full Text] [Related]
10. Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.
Silvers CR; Liu YR; Wu CH; Miyamoto H; Messing EM; Lee YF
Oncotarget; 2016 Apr; 7(17):23335-45. PubMed ID: 26981774
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway.
Gao Y; Liu S; Guo Q; Zhang S; Zhao Y; Wang H; Li T; Gong Y; Wang Y; Zhang T; Dong Z; Bacich D; Chowdhury WH; Rodriguez R; Wang Z
Int J Biol Sci; 2019; 15(7):1488-1499. PubMed ID: 31337978
[TBL] [Abstract][Full Text] [Related]
12. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
Starska K; Forma E; Lewy-Trenda I; Stasikowska O; Bryś M; Krajewska WM; Łukomski M
Folia Histochem Cytobiol; 2009 Jan; 47(3):401-10. PubMed ID: 20164024
[TBL] [Abstract][Full Text] [Related]
13. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C
BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
15. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
[TBL] [Abstract][Full Text] [Related]
17. NCR3LG1 (B7-H6) is a potential prognostic factor for bladder cancer patients.
Zhao L; Lian T; Li J; Wei S; Li H; Li C; Wang H
Biomarkers; 2021 May; 26(3):260-267. PubMed ID: 33523715
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.
Hofner T; Macher-Goeppinger S; Klein C; Schillert A; Eisen C; Wagner S; Rigo-Watermeier T; Baccelli I; Vogel V; Trumpp A; Sprick MR
Urol Oncol; 2014 Jul; 32(5):678-86. PubMed ID: 24631171
[TBL] [Abstract][Full Text] [Related]
19. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
